Loading…

The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection

Background. Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophage...

Full description

Saved in:
Bibliographic Details
Published in:Disease markers 2020, Vol.2020 (2020), p.1-7
Main Authors: Wang, Sheng, Jiang, Hui-fen, Wu, Jun-zhou, Song, Qian, Cai, Shu-nv
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853
cites cdi_FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853
container_end_page 7
container_issue 2020
container_start_page 1
container_title Disease markers
container_volume 2020
creator Wang, Sheng
Jiang, Hui-fen
Wu, Jun-zhou
Song, Qian
Cai, Shu-nv
description Background. Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. Methods. 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc=pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. Results. Kaplan-Meier curves revealed that LMRc≤1.59 was significantly associated with worse overall survival (OS) (P=0.003) and disease-free survival (DFS) (P=0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P=0.006, HR=0.687, 95% CI 0.526-0.898) and DFS (P=0.003, HR=0.640, 95% CI 0.476-0.859). Conclusions. LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation.
doi_str_mv 10.1155/2020/1451864
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7193282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A627689523</galeid><sourcerecordid>A627689523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEokvhxhlZ4oIES_0Rx_YFqYrKh7SoVWnPlteZJK4Se2snrfYP8TvxapdSOHGypXnmnXlHb1G8JvgjIZyfUEzxCSk5kVX5pFgQKfhSVgw_LRaYCrnEtMRHxYuUbjAmVJXqeXHEKBOCVnJR_LzqAV2ENIUNRDO5O0Cr7bjpg91OgKaAvge__1_makB1b3yXOyI0zk4pt4aI6sF5Z82AzufJhhGQ8-gi4-Azce-mHp2lsOlNB5n5cTubMcwJ1TAMqDbROh9Gg659A7ELzneong-rXEICm8f6l8Wz1gwJXh3e4-L689lV_XW5Ov_yrT5dLW2p1LRsRAtNS0AI1jBjjZC05VYS3mLLGszMmkHLVGnXa2MMrJVUQDjjljaiZJKz4-LTXnczr0dobHYQzaA30Y0mbnUwTv9d8a7XXbjTgihGJc0C7w4CMdzOkCY9umSzU-Mhm9aUKSXLshI79O0_6E2Yo8_2dpQoheL4EdWZAbTzbchz7U5Un1ZUVFJxyjL1YU_ZGFKK0D6sTLDexUTvYqIPMcn4m8c2H-DfucjA-z3QO9-Ye_efcpAZaM0fOh9XcMF-AdfU0l4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2397479502</pqid></control><display><type>article</type><title>The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection</title><source>Wiley Online Library Open Access</source><creator>Wang, Sheng ; Jiang, Hui-fen ; Wu, Jun-zhou ; Song, Qian ; Cai, Shu-nv</creator><contributor>Ashwood, Paul ; Paul Ashwood</contributor><creatorcontrib>Wang, Sheng ; Jiang, Hui-fen ; Wu, Jun-zhou ; Song, Qian ; Cai, Shu-nv ; Ashwood, Paul ; Paul Ashwood</creatorcontrib><description>Background. Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. Methods. 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc=pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. Results. Kaplan-Meier curves revealed that LMRc≤1.59 was significantly associated with worse overall survival (OS) (P=0.003) and disease-free survival (DFS) (P=0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P=0.006, HR=0.687, 95% CI 0.526-0.898) and DFS (P=0.003, HR=0.640, 95% CI 0.476-0.859). Conclusions. LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2020/1451864</identifier><identifier>PMID: 32377268</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Age ; Biomarkers ; Biomarkers, Tumor - blood ; Carcinoma, Squamous Cell - blood ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - surgery ; Chemotherapy ; Clinical outcomes ; Esophageal cancer ; Esophageal Neoplasms - blood ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; Esophagus ; Female ; Humans ; Inflammation ; Leukocyte Count ; Lung cancer ; Lymphatic system ; Lymphocytes ; Lymphocytes - pathology ; Male ; Medical prognosis ; Medical research ; Medicine, Experimental ; Metastasis ; Middle Aged ; Monocytes ; Monocytes - pathology ; Multivariate analysis ; Neutrophils ; Pathology ; Patient outcomes ; Patients ; Prognosis ; Radiation therapy ; Software ; Squamous cell carcinoma ; Statistical analysis ; Surgery ; Survival ; Treatment Outcome</subject><ispartof>Disease markers, 2020, Vol.2020 (2020), p.1-7</ispartof><rights>Copyright © 2020 Qian Song et al.</rights><rights>COPYRIGHT 2020 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2020 Qian Song et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Qian Song et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853</citedby><cites>FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853</cites><orcidid>0000-0002-3059-8897 ; 0000-0002-8115-3230 ; 0000-0003-4892-7537 ; 0000-0001-6575-1743 ; 0000-0002-4684-6744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32377268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ashwood, Paul</contributor><contributor>Paul Ashwood</contributor><creatorcontrib>Wang, Sheng</creatorcontrib><creatorcontrib>Jiang, Hui-fen</creatorcontrib><creatorcontrib>Wu, Jun-zhou</creatorcontrib><creatorcontrib>Song, Qian</creatorcontrib><creatorcontrib>Cai, Shu-nv</creatorcontrib><title>The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Background. Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. Methods. 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc=pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. Results. Kaplan-Meier curves revealed that LMRc≤1.59 was significantly associated with worse overall survival (OS) (P=0.003) and disease-free survival (DFS) (P=0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P=0.006, HR=0.687, 95% CI 0.526-0.898) and DFS (P=0.003, HR=0.640, 95% CI 0.476-0.859). Conclusions. LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation.</description><subject>Age</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - blood</subject><subject>Carcinoma, Squamous Cell - blood</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Chemotherapy</subject><subject>Clinical outcomes</subject><subject>Esophageal cancer</subject><subject>Esophageal Neoplasms - blood</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>Esophagus</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Leukocyte Count</subject><subject>Lung cancer</subject><subject>Lymphatic system</subject><subject>Lymphocytes</subject><subject>Lymphocytes - pathology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Monocytes</subject><subject>Monocytes - pathology</subject><subject>Multivariate analysis</subject><subject>Neutrophils</subject><subject>Pathology</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Radiation therapy</subject><subject>Software</subject><subject>Squamous cell carcinoma</subject><subject>Statistical analysis</subject><subject>Surgery</subject><subject>Survival</subject><subject>Treatment Outcome</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkk1v1DAQhiMEokvhxhlZ4oIES_0Rx_YFqYrKh7SoVWnPlteZJK4Se2snrfYP8TvxapdSOHGypXnmnXlHb1G8JvgjIZyfUEzxCSk5kVX5pFgQKfhSVgw_LRaYCrnEtMRHxYuUbjAmVJXqeXHEKBOCVnJR_LzqAV2ENIUNRDO5O0Cr7bjpg91OgKaAvge__1_makB1b3yXOyI0zk4pt4aI6sF5Z82AzufJhhGQ8-gi4-Azce-mHp2lsOlNB5n5cTubMcwJ1TAMqDbROh9Gg659A7ELzneong-rXEICm8f6l8Wz1gwJXh3e4-L689lV_XW5Ov_yrT5dLW2p1LRsRAtNS0AI1jBjjZC05VYS3mLLGszMmkHLVGnXa2MMrJVUQDjjljaiZJKz4-LTXnczr0dobHYQzaA30Y0mbnUwTv9d8a7XXbjTgihGJc0C7w4CMdzOkCY9umSzU-Mhm9aUKSXLshI79O0_6E2Yo8_2dpQoheL4EdWZAbTzbchz7U5Un1ZUVFJxyjL1YU_ZGFKK0D6sTLDexUTvYqIPMcn4m8c2H-DfucjA-z3QO9-Ye_efcpAZaM0fOh9XcMF-AdfU0l4</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Wang, Sheng</creator><creator>Jiang, Hui-fen</creator><creator>Wu, Jun-zhou</creator><creator>Song, Qian</creator><creator>Cai, Shu-nv</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TK</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3059-8897</orcidid><orcidid>https://orcid.org/0000-0002-8115-3230</orcidid><orcidid>https://orcid.org/0000-0003-4892-7537</orcidid><orcidid>https://orcid.org/0000-0001-6575-1743</orcidid><orcidid>https://orcid.org/0000-0002-4684-6744</orcidid></search><sort><creationdate>2020</creationdate><title>The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection</title><author>Wang, Sheng ; Jiang, Hui-fen ; Wu, Jun-zhou ; Song, Qian ; Cai, Shu-nv</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - blood</topic><topic>Carcinoma, Squamous Cell - blood</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Chemotherapy</topic><topic>Clinical outcomes</topic><topic>Esophageal cancer</topic><topic>Esophageal Neoplasms - blood</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>Esophagus</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Leukocyte Count</topic><topic>Lung cancer</topic><topic>Lymphatic system</topic><topic>Lymphocytes</topic><topic>Lymphocytes - pathology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Monocytes</topic><topic>Monocytes - pathology</topic><topic>Multivariate analysis</topic><topic>Neutrophils</topic><topic>Pathology</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Radiation therapy</topic><topic>Software</topic><topic>Squamous cell carcinoma</topic><topic>Statistical analysis</topic><topic>Surgery</topic><topic>Survival</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Sheng</creatorcontrib><creatorcontrib>Jiang, Hui-fen</creatorcontrib><creatorcontrib>Wu, Jun-zhou</creatorcontrib><creatorcontrib>Song, Qian</creatorcontrib><creatorcontrib>Cai, Shu-nv</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Sheng</au><au>Jiang, Hui-fen</au><au>Wu, Jun-zhou</au><au>Song, Qian</au><au>Cai, Shu-nv</au><au>Ashwood, Paul</au><au>Paul Ashwood</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Background. Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. Methods. 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc=pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. Results. Kaplan-Meier curves revealed that LMRc≤1.59 was significantly associated with worse overall survival (OS) (P=0.003) and disease-free survival (DFS) (P=0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P=0.006, HR=0.687, 95% CI 0.526-0.898) and DFS (P=0.003, HR=0.640, 95% CI 0.476-0.859). Conclusions. LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32377268</pmid><doi>10.1155/2020/1451864</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3059-8897</orcidid><orcidid>https://orcid.org/0000-0002-8115-3230</orcidid><orcidid>https://orcid.org/0000-0003-4892-7537</orcidid><orcidid>https://orcid.org/0000-0001-6575-1743</orcidid><orcidid>https://orcid.org/0000-0002-4684-6744</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-0240
ispartof Disease markers, 2020, Vol.2020 (2020), p.1-7
issn 0278-0240
1875-8630
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7193282
source Wiley Online Library Open Access
subjects Age
Biomarkers
Biomarkers, Tumor - blood
Carcinoma, Squamous Cell - blood
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - surgery
Chemotherapy
Clinical outcomes
Esophageal cancer
Esophageal Neoplasms - blood
Esophageal Neoplasms - pathology
Esophageal Neoplasms - surgery
Esophagus
Female
Humans
Inflammation
Leukocyte Count
Lung cancer
Lymphatic system
Lymphocytes
Lymphocytes - pathology
Male
Medical prognosis
Medical research
Medicine, Experimental
Metastasis
Middle Aged
Monocytes
Monocytes - pathology
Multivariate analysis
Neutrophils
Pathology
Patient outcomes
Patients
Prognosis
Radiation therapy
Software
Squamous cell carcinoma
Statistical analysis
Surgery
Survival
Treatment Outcome
title The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A11%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Postoperative%20Lymphocyte%20to%20Monocyte%20Ratio%20Change%20Predicts%20Poor%20Clinical%20Outcome%20in%20Patients%20with%20Esophageal%20Squamous%20Cell%20Carcinoma%20Undergoing%20Curative%20Resection&rft.jtitle=Disease%20markers&rft.au=Wang,%20Sheng&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2020/1451864&rft_dat=%3Cgale_pubme%3EA627689523%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-d7fedf1e773d3aca782f5c815f0c3d03ab3ef394cbbaaaeb989e1535c2d743853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2397479502&rft_id=info:pmid/32377268&rft_galeid=A627689523&rfr_iscdi=true